IL-28B reprograms tumor-associated macrophages to promote anti-tumor effects in colon cancer
International Immunopharmacology(2022)
摘要
•IL-28B inhibits colon cancer growth in a mouse colon cancer model.•IL-28B does not promote MC38 tumor cell apoptosis in vitro.•IL-28B inhibits M2 macrophages in the tumor microenvironment.•IL-28B truncates M2 macrophage differentiation.•IL-28B inhibits the STAT3 and JNK signaling pathways.
更多查看译文
关键词
IL-28B,Colorectal cancer,M2 macrophage,Cancer immunotherapy,Anti-tumor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要